Organ Absorbed and Effective Dose Estimated from Whole-Body 11C-4DST PET in Humans
| Organ | Absorbed dose (μGy/MBq) |
| Adrenals | 3.5 ± 0.1 (range, 3.4–3.5) |
| Brain | 2.0 ± 0.1 (range, 1.9–2.1) |
| Breasts | 2.0 ± 0.1 (range, 1.9–2.1) |
| Gallbladder wall | 4.0 ± 0.2 (range, 3.9–4.2) |
| Heart wall | 3.2 ± 0.2 (range, 3.0–3.5) |
| Kidneys | 13.6 ± 3.0 (range, 10.4–16.4) |
| Liver | 12.4 ± 2.3 (range, 10.9–15.0) |
| Lower large intestine wall | 2.9 ± 0.1 (range, 2.8–3.0) |
| Lungs | 2.8 ± 0.6 (range, 2.2–3.4) |
| Muscle | 2.4 ± 0.1 (range, 2.3–2.5) |
| Osteogenic cells | 4.7 ± 0.2 (range, 4.4–4.9) |
| Ovaries | 3.0 ± 0.1 (range, 2.9–3.1) |
| Pancreas | 3.4 ± 0.0 (range, 3.4–3.4) |
| Red marrow | 4.5 ± 0.6 (range, 3.9–5.0) |
| Skin | 1.9 ± 0.1 (range, 1.8–2.0) |
| Small intestine | 3.9 ± 0.3 (range, 3.6–4.2) |
| Spleen | 6.9 ± 1.4 (range, 5.5–8.2) |
| Stomach wall | 2.8 ± 0.1 (range, 2.7–2.9) |
| Testes | 2.3 ± 0.1 (range, 2.2–2.4) |
| Thymus | 2.4 ± 0.1 (range, 2.3–2.5) |
| Thyroid | 2.3 ± 0.1 (range, 2.1–2.4) |
| Upper large intestine wall | 3.0 ± 0.1 (range, 2.9–3.1) |
| Urinary bladder wall | 17.6 ± 2.7 (range, 15.3–20.6) |
| Uterus | 3.4 ± 0.0 (range, 3.4–3.4) |
| Total body | 2.8 ± 0.0 (range, 2.8–2.8) |
Data are mean ± SD and range for healthy subjects (n = 3). Effective dose is 4.2 ± 0.3 (range, 4.0–4.5) μSv/MBq.